Endoscopic Trigger Finger Release
- Disease/Condition
- Trigger Finger
- Drug/Device/Intervention
- Endoscopic Release
- Study type
- Interventional
- Intervention type
- device
- Primary sponsor
- Cedars-Sinai Medical Center
- Location
- Los Angeles, United States of America
- Phase
- N/A
- Start date
- Mar 13, 2019
- End date
- Dec 01, 2021
- Enrollment
- 24 participants
Scar comparison between treatment arms, as measured by the Patient and Observer Scar Assessment Scale (POSAS)
The purpose of this study is to compare recovery, scar, and patient satisfaction after
 retrograde endoscopic trigger finger release versus the standard open surgical treatment.
- Registry
- ClinicalTrials.gov
- Trial ID
- NCT03883477
- Type
- Device Trial
Access comprehensive clinical trial information for NCT03883477 through Pure Global AI's free database. This phase not specified trial is sponsored by Cedars-Sinai Medical Center and is currently Enrolling by invitation. The study focuses on Trigger Finger. Target enrollment is 24 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.